Leukocytoclastic vasculitis as a cutaneous paraneoplastic syndrome in malignant mesothelioma

Our plain-English summary of Leukocytoclastic vasculitis as a cutaneous paraneoplastic syndrome in malignant mesothelioma, by H.J. Kwon, K.D. Park, J.H. Yoon (JAAD Case Reports, 2022).

The study

• Authors: H.J. Kwon, K.D. Park, J.H. Yoon
• Journal: JAAD Case Reports
• Published: 2022;26:20-22
• Type of article: Case report
• Cited by: 1 article, as counted by NIH iCite
• Read it: PubMed · Publisher · Free full text

In plain English

This case report described one 59-year-old Korean man with malignant mesothelioma who reported 35 years of asbestos exposure at his workplace. The article did not name a fiber type. A figure caption described the tumor as a malignant pericardial mesothelioma. One week after the mesothelioma was diagnosed, without metastasis, he was seen for red, ulcerated patches on both legs that had lasted about 2 months. A skin biopsy showed leukocytoclastic vasculitis, an inflammation of small blood vessels in the skin. Treatment with a steroid, an antihistamine and an antibiotic brought no significant improvement after 2 weeks, and many blood tests showed no significant findings. He then received 10 cycles of pemetrexed and cisplatin chemotherapy. The tumor shrank and the skin lesions partially improved. No recurrence of vasculitis or tumor progression was seen over 3 more months of follow-up. The authors hypothesized that the vasculitis arose from the mesothelioma as a paraneoplastic syndrome. They noted that the short follow-up meant they could not confirm that the two conditions followed parallel courses.

We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.

What the study did and found

• Design: case report (single patient)
• Who was studied: One 59-year-old Korean man with malignant mesothelioma, seen at the Department of Dermatology, Dong-A University, Busan, Republic of Korea
• Exposure: Self-reported workplace asbestos exposure for 35 years; no fiber type, product or job specified
• Main results:
  • The patient had been diagnosed with malignant mesothelioma without metastasis 1 week before the dermatology visit
  • A figure caption identified the tumor as a malignant pericardial mesothelioma
  • The skin biopsy showed features of leukocytoclastic vasculitis, with vascular wall destruction and necrotic changes
  • Prednisolone, cetirizine and cefaclor gave no significant improvement after 2 weeks
  • Blood and laboratory tests, including autoantibody tests, showed no significant findings
  • The patient was treated with pemetrexed and cisplatin every 3 weeks for 10 cycles
  • The tumor size decreased during chemotherapy
  • During chemotherapy the ulcerative patches disappeared and the red patches partially improved
  • No vasculitis recurrence or tumor progression was seen in 3 months of follow-up after the last chemotherapy cycle
• The authors' conclusion: The authors hypothesized that the leukocytoclastic vasculitis was derived from the mesothelioma as a cutaneous paraneoplastic syndrome. They suggested it could serve as a clinical marker for detecting malignancies.
• Limitations the authors state:
  • The relatively short follow-up makes it debatable whether the vasculitis and the cancer truly followed parallel courses
  • The case did not show vasculitis returning ahead of tumor recurrence or progression, which the authors described as stronger evidence of parallel courses
  • The authors could not prove their proposed immune-complex mechanism because of the insufficient observation period

Topics

Medical terms in this study, explained in our Lexicon: Mesothelioma.

Related studies

• Paraneoplastic leukocytoclastic vasculitis as an initial presentation of malignant pleural mesothelioma: a case report — S.F. Wong, L. Newland, et al. (2012)
• Mesothelioma and anti-Ma paraneoplastic syndrome; heterogeneity in immunogenic tumours increases — H.A. Archer, A. Panopoulou, et al. (2014)
• Recurrent thrombotic thrombocytopenic purpura-like syndrome as a paraneoplastic phenomenon in malignant peritoneal mesothelioma: a case report and review of the literature — F. Socola, A. Loaiza-Bonilla, et al. (2012)
• Thrombocytosis as a paraneoplastic syndrome in metastatic malignant peritoneal mesothelioma of biphasic morphology mimicking ovarian adenocarcinoma: A case report — M.S. Alhamadh, R.B. Alanazi, et al. (2023)
• Metachronous double primary malignant tumors with nasopharyngeal carcinoma and diffuse malignant peritoneal mesothelioma accompanied with paraneoplastic syndromes treated with nivolumab: A case report — L.K. Tang, Z.K. Li, et al. (2023)
• Risk factors and prognosis of malignant peritoneal mesothelioma with paraneoplastic syndrome — X.L. Liang, Y.D. Su, et al. (2024)

Browse return to medical research.